NOROVIRUS ACUTE GASTROENTERITIS
Clinical trials for NOROVIRUS ACUTE GASTROENTERITIS explained in plain language.
Never miss a new study
Get alerted when new NOROVIRUS ACUTE GASTROENTERITIS trials appear
Sign up with your email to follow new studies for NOROVIRUS ACUTE GASTROENTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests first mRNA shot against widespread 'Stomach Bug'
⭐️ VACCINE ⭐️ OngoingThis large, late-stage study is testing an experimental mRNA vaccine designed to prevent norovirus, a common cause of severe stomach flu. It will enroll over 37,000 adults to see if the vaccine is safe and if it can stop moderate or severe cases of vomiting and diarrhea caused by…
Matched conditions: NOROVIRUS ACUTE GASTROENTERITIS
Phase: PHASE3 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:34 UTC
-
Moderna tests mRNA shots to stop stomach bug outbreaks
⭐️ VACCINE ⭐️ OngoingThis study is testing two new mRNA vaccines, mRNA-1403 and mRNA-1405, designed to prevent norovirus, a common cause of severe stomach flu. It will involve about 1,400 healthy adults aged 18 to 80 to check if the vaccines are safe and if they trigger a good immune response. The re…
Matched conditions: NOROVIRUS ACUTE GASTROENTERITIS
Phase: PHASE1, PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 20, 2026 14:48 UTC